ES2408932T3 - Síntesis y uso de agentes antibacterianos heterocíclicos - Google Patents

Síntesis y uso de agentes antibacterianos heterocíclicos Download PDF

Info

Publication number
ES2408932T3
ES2408932T3 ES09770902T ES09770902T ES2408932T3 ES 2408932 T3 ES2408932 T3 ES 2408932T3 ES 09770902 T ES09770902 T ES 09770902T ES 09770902 T ES09770902 T ES 09770902T ES 2408932 T3 ES2408932 T3 ES 2408932T3
Authority
ES
Spain
Prior art keywords
phenyl
compound
substituted
formula
ethynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09770902T
Other languages
English (en)
Spanish (es)
Inventor
Panduranga Adulla P. Reddy
Umar Faruk Mansoor
M. Arshad Siddiqui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Merck Sharp & Dohme LLC
Original Assignee
Merck Sharp and Dohme Ltd
Merck Sharp & Dohme LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd, Merck Sharp & Dohme LLC filed Critical Merck Sharp and Dohme Ltd
Application granted granted Critical
Publication of ES2408932T3 publication Critical patent/ES2408932T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
ES09770902T 2008-06-25 2009-06-24 Síntesis y uso de agentes antibacterianos heterocíclicos Active ES2408932T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7538308P 2008-06-25 2008-06-25
US75383 2008-06-25
PCT/US2009/048368 WO2009158369A1 (en) 2008-06-25 2009-06-24 Synthesis and use of heterocyclic antibacterial agents

Publications (1)

Publication Number Publication Date
ES2408932T3 true ES2408932T3 (es) 2013-06-24

Family

ID=41059643

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09770902T Active ES2408932T3 (es) 2008-06-25 2009-06-24 Síntesis y uso de agentes antibacterianos heterocíclicos

Country Status (6)

Country Link
US (1) US20110212078A1 (enExample)
EP (1) EP2307365B1 (enExample)
JP (1) JP2011525927A (enExample)
CA (1) CA2728210A1 (enExample)
ES (1) ES2408932T3 (enExample)
WO (1) WO2009158369A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2691987C (en) 2007-06-12 2016-08-16 Achaogen, Inc. Antibacterial agents
US9738604B2 (en) 2010-09-03 2017-08-22 Duke University Ethynylbenzene derivatives
WO2013170165A1 (en) 2012-05-10 2013-11-14 Achaogen, Inc. Antibacterial agents
WO2014165075A1 (en) 2013-03-12 2014-10-09 Achaogen, Inc. Antibacterial agents
WO2015024011A2 (en) 2013-08-16 2015-02-19 Duke University Antibacterial compounds
AU2014306451B2 (en) 2013-08-16 2019-01-17 Duke University Substituted hydroxamic acid compounds
WO2015024016A2 (en) 2013-08-16 2015-02-19 Duke University 2-piperidinyl substituted n,3-dihydroxybutanamides
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
US10011611B2 (en) 2015-08-14 2018-07-03 Reaction Biology Corp. Histone deacetylase inhibitors and methods for use thereof
WO2017223349A1 (en) 2016-06-23 2017-12-28 Achaogen, Inc. Antibacterial agents
GB2562777A (en) * 2017-05-25 2018-11-28 Taisho Pharmaceutical Co Ltd Novel alpha-amino amide derivatives
ES2927480T3 (es) * 2017-06-02 2022-11-07 Hoffmann La Roche Compuestos de isoindolina-acetileno para el tratamiento del cáncer
WO2018220149A1 (en) 2017-06-02 2018-12-06 F. Hoffmann-La Roche Ag Compounds
IL279800B2 (en) 2018-06-29 2024-02-01 Hoffmann La Roche Selective allosteric inhibitors of epidermal growth factor receptor mutants, pharmaceutical preparations containing them and their use
TW202115073A (zh) 2019-06-21 2021-04-16 瑞士商赫孚孟拉羅股份公司 新穎的egfr抑制劑
ES2961187T3 (es) 2019-06-21 2024-03-08 Hoffmann La Roche Inhibidor de EGFR para el tratamiento del cáncer
CN110498783A (zh) * 2019-08-02 2019-11-26 成都蓝蜻蜓生物技术有限公司 一种合成罗沙司他中间体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925659A (en) * 1996-05-07 1999-07-20 Merck & Co., Inc. Antibacterial agents
AU2594799A (en) 1998-02-11 1999-08-30 Du Pont Pharmaceuticals Company Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
EP1053246B1 (en) * 1998-02-12 2003-01-02 Molecumetics, Ltd. Beta-sheet mimetics and methods relating to the use thereof
JP4020290B2 (ja) 2000-09-14 2007-12-12 独立行政法人科学技術振興機構 光学活性ヒドロキサム酸
DE10227464A1 (de) 2002-06-20 2004-01-08 Technische Universität Braunschweig Glaszusammensetzung zur Herstellung von optischen Übertragungselementen
ES2387803T3 (es) 2003-01-08 2012-10-02 Novartis Vaccines And Diagnostics, Inc. Agentes antibacterianos
JP2009520689A (ja) 2005-12-01 2009-05-28 シェーリング コーポレイション 炎症障害および微生物性疾患を処置するための化合物
CN101528711A (zh) * 2006-08-31 2009-09-09 先灵公司 可用作抗细菌剂的乙内酰脲衍生物
CA2691987C (en) * 2007-06-12 2016-08-16 Achaogen, Inc. Antibacterial agents

Also Published As

Publication number Publication date
JP2011525927A (ja) 2011-09-29
EP2307365A1 (en) 2011-04-13
WO2009158369A1 (en) 2009-12-30
US20110212078A1 (en) 2011-09-01
CA2728210A1 (en) 2009-12-30
EP2307365B1 (en) 2013-03-27

Similar Documents

Publication Publication Date Title
EP2307365B1 (en) Synthesis and use of heterocyclic antibacterial agents
EP2057127B1 (en) Hydantoin derivatives useful as antibacterial agents
US20110212080A1 (en) Urea derivatives as antibacterial agents
ES2924522T3 (es) Inhibidores heteroarilo de PAD4
RU2536865C2 (ru) Производные тиофена
CN110770242B (zh) 作为vanin抑制剂的杂芳族化合物
CN115835866B (zh) Cereblon结合化合物、其组合物及其用于治疗的方法
ES2816641T3 (es) Derivados de piperidina en calidad de inhibidores de HDAC1/2
PT931063E (pt) Indol-3-glioxilamidas n-substituídas com efeito anti-asmático, anti-alérgico e imunossupressor/imunomodulador
KR20080070876A (ko) 염증 질환 및 미생물 질병 치료용 조성물
ES2881681T3 (es) 3,4-Dihidro-1H-[1,8]naftiridinonas sustituidas con piperidinilo antibacterianas
CN102482219A (zh) 吡喃酮和吡啶酮衍生物的制备方法
BRPI0719861A2 (pt) Compostos heteroaromáticos bicíclicos
TW200906401A (en) Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
ES2776145T3 (es) 3,4-Dihidro-1h-[1,8]naftiridinonas sustituidas con homopiperidinilo antibacterianas
JP6434528B2 (ja) 置換ピリドン及びピラジノン、並びに好中球エラスターゼ活性の阻害剤としてのその使用
ES2303532T3 (es) Nuevos derivados de indol y su uso como medicamentos.
CN103242210B (zh) 含有取代方酸的乙酸妙林酯及其应用
US5574039A (en) Antiproliferative compounds having nitrogen-containing tricyclic ring systems and phenyl substituents
KR20100132553A (ko) 신규한 ｎ-(2-아미노-페닐)-아크릴아미드
ES2251234T3 (es) Nuevos derivados de pirimidina y proceso para su preparacion.
ES2981840T3 (es) Derivados de isoquinolina para su uso en el tratamiento del síndrome de deficiencia de GLUT1
PT2094653E (pt) Derivados de o-substituído-dibenzilureia como antagonistas do receptor trpv1
JP2018517720A (ja) 新規ホスホジエステラーゼ５阻害剤とその使用
JPH0812672A (ja) チアジアジノン誘導体